Latest News and Press Releases
Want to stay updated on the latest news?
-
LUXEMBOURG, Nov. 07, 2025 (GLOBE NEWSWIRE) -- Caladium may still be under the radar in financial-media terms, but its emerging role securing ~US$345 million from Chinese and Indian backers to invest...
-
Delhi, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Kuick Research has unveiled its latest comprehensive report on the Global Cancer Antibody Drug Conjugate (ADC) Market, a 1300 page study that serves as a...
-
BETHESDA, Md., Oct. 16, 2025 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of...
-
LONDON, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Commodity traders are facing renewed geopolitical risks as military conflicts proliferate, tariffs increase, and global supply chains come under pressure,...
-
SALT LAKE CITY, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine Inc., a clinical-stage...
-
Dublin, Oct. 13, 2025 (GLOBE NEWSWIRE) -- The "Li-ion Battery Cathode Active Material Recycling Patent Landscape Analysis 2025" report has been added to ResearchAndMarkets.com's offering. The...
-
Seattle, WA, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Gainwize, an investment research platform, has launched its proprietary Ripple Maps technology to help retail investors identify under-the-radar...
-
ZURICH, Sept. 11, 2025 (GLOBE NEWSWIRE) -- 21Shares today announced the launch of the 21Shares DYDX Exchange-Traded Product (ETP), a regulated, physically backed investment product providing...
-
SAN FRANCISCO, Aug. 26, 2025 (GLOBE NEWSWIRE) -- On June 20, 2025 investors in KBR, Inc. (NYSE: KBR) saw the price of their shares decline over 7% after the company announced that the Department of...
-
IMDX CFO Andrea James Featured in Empowered Patient Podcast on Democratizing Molecular Diagnostics